Search research articles
Contact Us
Filters
Showing results (21-30 of 99) with videos related to
Page
of 10
Sort By:
BMC Health Services Research
|
December 23, 2025
Multi-stakeholder validation of an evidence-based core set of quality indicators for IBD in Belgium
Liselotte Fierens, Frank E Rademakers, Peter Bossuyt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 1, 2025
Diagnosis of Retrograde Cricopharyngeus Dysfunction Using High Resolution Impedance Manometry and Comparison With Control Subjects
Karlien Raymenants, Friedel Vulsteke, Tim Vanuytsel, et al.
Acta Clinica Belgica
|
January 27, 2021
Antimicrobial resistance of <i>Helicobacter pylori</i> in West Flanders - Belgium: an observational cross-sectional study
Alexander Vanden Bulcke, Bruno Waked, Lise Haems, et al.
European Journal of Gastroenterology & Hepatology
|
June 25, 2024
Development of a set of measurable outcome indicators for Flemish patients with inflammatory bowel disease
Liselotte Fierens, Peter Bossuyt, Filip Baert, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 4, 2014
Early trough levels and antibodies to infliximab predict safety and success of reinitiation of infliximab therapy
Filip Baert, David Drobne, Ann Gils, et al.
Clinical Chemistry and Laboratory Medicine
|
February 21, 2024
Analytical and diagnostic performance of Theradiag i-Tracker assays on IDS-iSYS for infliximab and adalimumab therapeutic drug monitoring
Pauline Herroelen, Hilde Vanpoucke, Filip Baert, et al.
Journal of Crohn'S & Colitis
|
March 2, 2019
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study
Niels Vande Casteele, Filip Baert, Sumin Bian, et al.
Gastroenterology
|
July 10, 2003
Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study
Severine Vermeire, Maja Noman, Gert Van Assche, et al.
Gut
|
April 12, 2015
Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial
Filip Baert, Venkateswarlu Kondragunta, Steven Lockton, et al.
Journal of Crohn'S & Colitis
|
April 28, 2012
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients
Filip Baert, Elien Glorieus, Cathérine Reenaers, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 99) with videos related to
Sort By:
Page
of 10
BMC Health Services Research
|
December 23, 2025
Multi-stakeholder validation of an evidence-based core set of quality indicators for IBD in Belgium
Liselotte Fierens, Frank E Rademakers, Peter Bossuyt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 1, 2025
Diagnosis of Retrograde Cricopharyngeus Dysfunction Using High Resolution Impedance Manometry and Comparison With Control Subjects
Karlien Raymenants, Friedel Vulsteke, Tim Vanuytsel, et al.
Acta Clinica Belgica
|
January 27, 2021
Antimicrobial resistance of <i>Helicobacter pylori</i> in West Flanders - Belgium: an observational cross-sectional study
Alexander Vanden Bulcke, Bruno Waked, Lise Haems, et al.
European Journal of Gastroenterology & Hepatology
|
June 25, 2024
Development of a set of measurable outcome indicators for Flemish patients with inflammatory bowel disease
Liselotte Fierens, Peter Bossuyt, Filip Baert, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 4, 2014
Early trough levels and antibodies to infliximab predict safety and success of reinitiation of infliximab therapy
Filip Baert, David Drobne, Ann Gils, et al.
Clinical Chemistry and Laboratory Medicine
|
February 21, 2024
Analytical and diagnostic performance of Theradiag i-Tracker assays on IDS-iSYS for infliximab and adalimumab therapeutic drug monitoring
Pauline Herroelen, Hilde Vanpoucke, Filip Baert, et al.
Journal of Crohn'S & Colitis
|
March 2, 2019
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study
Niels Vande Casteele, Filip Baert, Sumin Bian, et al.
Gastroenterology
|
July 10, 2003
Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study
Severine Vermeire, Maja Noman, Gert Van Assche, et al.
Gut
|
April 12, 2015
Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial
Filip Baert, Venkateswarlu Kondragunta, Steven Lockton, et al.
Journal of Crohn'S & Colitis
|
April 28, 2012
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients
Filip Baert, Elien Glorieus, Cathérine Reenaers, et al.
Page
of 10